Results 1 to 10 of about 2,709,028 (237)

Interleukin 35: protective role and mechanism in type 1 diabetes [PDF]

open access: yesCentral European Journal of Immunology, 2023
Interleukin 35 (IL-35), a cytokine secreted by regulatory T (Treg) cells from the differentiation of conventional CD4+ T cells, is a member of the IL-12 family. The IL-12 family of cytokines exhibits an anti-inflammatory property. IL-35 has recently been
Si-Ming Zhang   +8 more
doaj   +3 more sources

Interleukin-35 pathobiology in periodontal disease: a systematic scoping review [PDF]

open access: yesBMC Oral Health, 2021
Background Interleukin (IL)-35 is a novel anti-inflammatory cytokine that is produced by regulatory T cells. IL-35 mediates immunological functions and plays a protective role in several diseases such as asthma and rheumatoid arthritis. However, the role
Patrick R. Schmidlin   +2 more
doaj   +3 more sources

The diagnostic value of interleukin 35 as a septic biomarker: A meta-analysis [PDF]

open access: yesFrontiers in Medicine, 2022
BackgroundThere is growing evidence that interleukin 35 (IL-35) represents a potential diagnostic biomarker for sepsis. The purpose of this meta-analysis was to evaluate the overall diagnostic accuracy of IL-35 in sepsis.Materials and methodsFrom October
Yuanhui Hu, Dongling Tang, Pingan Zhang
doaj   +2 more sources

Reduced circulating interleukin 35 is associated with enhanced peripheral T cell function in primary biliary cholangitis [PDF]

open access: yesBiomolecules & Biomedicine, 2023
Interleukin 35 (IL-35) mediates immunosuppression of T cells in autoimmune diseases. T cells play an important role in primary biliary cholangitis (PBC) with incompletely elucidated pathogenesis. Thus, we aimed to investigate the role of IL-35 regulation
Siqi Liu   +6 more
doaj   +2 more sources

Interleukin-35 in autoimmune dermatoses: Current concepts [PDF]

open access: yesOpen Medicine, 2022
Interleukin-35 (IL-35) is a lately observed cytokine and is part of the IL-12 cytokine family. IL-35 includes two subunits, p35 and Epstein-Barr virus-induced gene 3, and activates subsequent signaling pathways by binding to receptors to mediate signal ...
Xie Yuming   +3 more
doaj   +2 more sources

High interleukin-35 expression is associated with the severity of rheumatic mitral stenosis [PDF]

open access: yesFrontiers in Immunology
BackgroundRheumatic mitral stenosis (RMS) is the most common manifestation of rheumatic heart disease, with high morbidity and mortality. Interleukin-35 (IL-35) is a novel anti-inflammatory cytokine associated with many autoimmune diseases.
Ping Wang   +8 more
doaj   +2 more sources

Interleukin 35 promotes progression of hepatocellular carcinoma by recruiting neutrophils [PDF]

open access: yesTranslational Oncology
Background: A growing number of therapeutic strategies against hepatocellular carcinoma (HCC) have emerged. However, their efficacy remains limited.
Wei Gan   +8 more
doaj   +2 more sources

Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis [PDF]

open access: yesFrontiers in Pharmacology, 2021
It is well known that RA (Rheumatoid arthritis) is an autoimmune disease characterized by multiple and symmetric arthropathy. The main pathological features of RA are synovial hyperplasia, angiogenesis, pannus formation, inflammatory cell infiltration ...
Pan Lin Xin   +4 more
doaj   +2 more sources

Immunomodulatory cytokine interleukin-35 and immune thrombocytopaenia [PDF]

open access: yesJournal of International Medical Research, 2020
Considerable attention has been paid to interleukin (IL)-35 because of its immunosuppressive effects in a variety of autoimmune diseases. IL-35, a recently identified cytokine of the IL-12 family, is a negative regulatory factor secreted by IL-35 ...
Jing-Jing Zhu, Ning-Ning Shan
doaj   +2 more sources

Interleukin-35 Is Involved in Angiogenesis/Bone Remodeling Coupling Through T Helper 17/Interleukin-17 Axis [PDF]

open access: yesFrontiers in Endocrinology, 2021
ObjectiveOsteoporosis is a common metabolic bone disease mainly involving bone remodeling and blood vessels. The current study aimed to explore the suppressive role of interleukin (IL)-35 in nuclear factor kappa-B ligand receptor activator (RANKL) and ...
Hui Zhang   +7 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy